EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing the Potential of mRNA Vaccines Against Infectious Diseases

Nouran Rezk iD, Siobhán McClean iD

Microbial Biotechnology · 2025-08 · 18 (8)

DOI: 10.1111/1751-7915.70212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Biotechnology, online erschienen am 25.08.2025. Verfasst von Nouran Rezk und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Vaccines, Synthetic, mRNA Vaccines, Communicable Diseases, RNA, Messenger. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Higher Education Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

mRNA vaccines have emerged as promising alternatives to conventional vaccines because of their flexible design, high immunogenicity, favourable safety profile, efficacy and potential for rapid clinical development. The accelerated development of mRNA vaccines during the COVID‐19 pandemic has revolutionised the field of vaccinology, highlighting their potential for combating emerging infectious diseases. The mRNA platforms can induce robust humoral as well as CD4+ and CD8+ T‐cell‐mediated immunity, offering broader protection than subunit protein vaccines. Consequently, they have been extensively studied against a wide range of viral, bacterial and parasitic infections, although the development of mRNA vaccines against bacterial and parasitic infections has lagged behind those targeting viruses. This review highlights recent studies on mRNA vaccine development and applications against a wide range of infectious diseases including non‐COVID viral infections, bacterial pathogens such as Mycobacteria or Pseudomonas aeruginosa and parasitic infections, including malaria. Moreover, it discusses key optimisation strategies and highlights candidates that have progressed to clinical trials, and the current challenges in enhancing immunogenicity and improving delivery systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, SyntheticmRNA VaccinesCommunicable DiseasesRNA, MessengerHumansVaccine DevelopmentCOVID-19Bacterial InfectionsParasitic DiseasesBacterial VaccinesAnimalsSARS-CoV-2

Stichwörter der Autor:innen

Pseudomonas aeruginosaMycobacteriabacterial infectionclinical trialsdengueinfluenzamRNA vaccinesmalariaparasitic infection

Substanzen

Vaccines, SyntheticmRNA VaccinesBacterial VaccinesRNA, Messenger

Autor:innen und Institutionen

  • School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

ORCID-Profile: Nouran Rezk, Siobhán McClean

Förderung

  • Higher Education Authority

Zitieren

APA

Rezk, N., & McClean, S. (2025). Harnessing the Potential of mRNA Vaccines Against Infectious Diseases. Microbial Biotechnology, 18(8). https://doi.org/10.1111/1751-7915.70212

Vancouver

Rezk N, McClean S. Harnessing the Potential of mRNA Vaccines Against Infectious Diseases. Microbial Biotechnology. 2025;18(8). doi:10.1111/1751-7915.70212

BibTeX
@article{Rezk2025,
  author = {Rezk, Nouran and McClean, Siobhán},
  title = {Harnessing the Potential of mRNA Vaccines Against Infectious Diseases},
  journal = {Microbial Biotechnology},
  year = {2025},
  volume = {18},
  number = {8},
  doi = {10.1111/1751-7915.70212}
}
Kostenlos starten →